Diagnostic marker

Diagnostic performance of microRNA-29a for colorectal cancer: a meta-analysis

M. L. Zhi, Liu, Z. J., Yi, X. Y., Zhang, L. J., and Bao, Y. X., Diagnostic performance of microRNA-29a for colorectal cancer: a meta-analysis, vol. 14, pp. 18018-18025, 2015.

Previous studies have revealed that the expression level of microRNA-29a (miR-29a) was remarkably different in colorectal cancer (CRC) patients and healthy controls, indicating that miR-29a can be used as a diagnostic marker of CRC, but the results have been inconsistent. We conducted this meta-analysis to assess the diagnostic performance of blood-based miR-29a for CRC. We performed a systematic review of studies published over the past two decades to investigate the diagnostic performance of serum miR-29a for the diagnosis of CRC.

Subscribe to Diagnostic marker